Esophageal Dilation denied as duplicate or overlapping therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for esophageal dilation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denies Esophageal Dilation as Duplicate Therapy

Esophageal dilation is an endoscopic procedure used to widen a narrowed esophagus caused by conditions such as strictures, achalasia, or rings. A duplicate-therapy denial typically arises when BCBS's claim-processing system detects that an esophageal dilation procedure code was billed in close temporal proximity to another esophageal or gastrointestinal procedure — such as an upper endoscopy (EGD) — and the plan's logic treats them as overlapping or redundant. This can also occur when a dilation is performed during an EGD and the plan bundles the dilation into the base endoscopy code.

## Why This Denial Is Appealable

Duplicate-therapy denials for procedural services are frequently the result of automated claim-bundling logic rather than a clinical determination that the procedure was unnecessary. If the dilation was performed as a separate and distinct intervention — or if it was clinically necessary in addition to any other procedure performed — the clinical record and a correct understanding of the billing codes support reversal. The appeal should address both the clinical necessity and the coding rationale.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / ACA §2719): Submit within the deadline in the Explanation of Benefits or denial letter. Include a clinical and coding rationale.
• External review (ACA §2719): After a final internal denial, request Independent Review Organization review within approximately four months of the final denial. The IRO assesses both clinical necessity and whether the plan's bundling logic was correctly applied.
• Expedited review: Available for urgent cases — request it simultaneously with the standard appeal if the patient has ongoing dysphagia or a risk of aspiration.

## Concrete Appeal Steps

1. Obtain the Explanation of Benefits showing the exact denial reason code and the procedure codes at issue. 2. Have the proceduralist review the operative report to confirm that the dilation was a distinct clinical intervention. 3. Request a coding review from the practice's billing department to confirm correct CPT code assignment. 4. Draft an appeal letter addressing both the clinical necessity and the claim-bundling argument. 5. Submit with the documentation package below. 6. If denied internally, escalate to IRO external review.

## Documentation to Gather

• Procedure report / operative note: The complete endoscopy report describing the dilation as a distinct intervention with its own clinical rationale.
• Diagnosis documentation: Chart notes confirming the esophageal condition (stricture, ring, achalasia, or other) that required dilation.
• Prior-treatment history: Notes showing the chronology of prior dilations or other esophageal interventions, with dates and outcomes, to establish recurrent medical necessity.
• Prescriber/proceduralist medical-necessity letter: A letter from the gastroenterologist or surgeon explaining why dilation was clinically necessary at this encounter, separate from any other procedure performed.
• Coding justification: A written explanation from the billing team explaining why the dilation code was billed separately and why it was not properly bundled under the plan's logic.

## Criteria-Mapping Structure

Pull BCBS's applicable clinical and billing policy for esophageal dilation from the BCBS provider portal. Build a two-column table: left column = each coverage requirement and any bundling rule, copied verbatim; right column = the specific clinical or billing evidence satisfying or rebutting each point.